CYTOGENETIC STUDIES IN PATIENTS WITH MYELOFIBROSIS AND MYELOID METAPLASIA

被引：63
|
作者：
WHANGPENG, J [1 ]
LEE, E [1 ]
KNUTSEN, T [1 ]
CHANG, P [1 ]
NIENHUIS, A [1 ]
机构：
[1] UNIV MARYLAND HOSP,BALTIMORE CANCER RES CTR,BALTIMORE,MD 21201
来源：
LEUKEMIA RESEARCH | 1978年 / 2卷 / 01期
关键词：
D O I：
10.1016/0145-2126(78)90006-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：41 / &
相关论文
共 50 条
  • [21] SPLENECTOMY IN MYELOFIBROSIS AND MYELOID METAPLASIA
    CHAIMOFF, C
    AMIR, J
    VRIES, AD
    HAREFUAH, 1974, 87 (05) : 211 - 212
  • [22] MYELOFIBROSIS MYELOID METAPLASIA IN CHILDHOOD
    BOXER, LA
    CAMITTA, BM
    BERENBERG, W
    FANNING, JP
    PEDIATRICS, 1975, 55 (06) : 861 - 865
  • [23] Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia
    Petroianu, A
    INTERNATIONAL SURGERY, 1996, 81 (02) : 177 - 179
  • [24] Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia
    Barosi, G
    Grossi, A
    Comotti, B
    Musto, P
    Gamba, G
    Marchetti, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) : 78 - 83
  • [25] PROGRESSIVE MYELOFIBROSIS IN AGNOGENIC MYELOID METAPLASIA
    LOHMANN, TP
    BECKMAN, EN
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1983, 107 (11) : 593 - 594
  • [26] Enhanced histone deacetylase activity in patients with myelofibrosis myeloid metaplasia
    Wang, J.
    Chang, T.
    Xiao, Y.
    Sominsky, I.
    Astrow, A.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 65 - 65
  • [27] Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia
    M. Merup
    J. Kutti
    G. Birgergård
    N. Mauritzson
    M. Björkholm
    B. Markevärn
    C. Malm
    J. Westin
    J. Palmblad
    J. Samuelsson
    Medical Oncology, 2002, 19 : 79 - 86
  • [28] PROGRESSIVE MYELOFIBROSIS IN AGNOGENIC MYELOID METAPLASIA
    BECKER, EN
    LOHMANN, TP
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1983, 80 (01) : 113 - 113
  • [29] Thalidomide: no benefit in myelofibrosis with myeloid metaplasia
    Bonn, D
    LANCET ONCOLOGY, 2003, 4 (02): : 70 - 70
  • [30] Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia
    Merup, M
    Kutti, J
    Birgergård, G
    Mauritzson, N
    Björkholm, M
    Markevärn, B
    Malm, C
    Westin, J
    Palmblad, J
    Samuelsson, J
    MEDICAL ONCOLOGY, 2002, 19 (02) : 79 - 86
12345